本页仅为文字内容，不可回答。
Novartis China One Risk Workshop - CLT feedback
Dear all, please kindly share with us your feedback regarding One Risk Workshop practice in China, though the experience of divisional workshops recently and country-level workshop on June 18th. Appreciate if you can complete the survey by July 10th. Thank you!
What were your key learnings from this overall exercise?
What were the surprise elements for you as CLT in terms of risk areas that you never considered in the past?
Were there any discrepancies in assessing similar risks across different business units? If so, how did you address such risk areas?
How did this exercise benefit your organization?
How do you plan to incorporate these risk assessment results into your overall business strategy and operational goals targets and objectives?
Any other feedback or comments
